8-K Announcements
6Material company update
Apr 30, 2026·SEC
Material company update
Apr 9, 2026·SEC
Material company update
Mar 31, 2026·SEC
Labcorp Holdings Inc.(LH)Earnings, Financials & Key Ratios
LH•NYSE
24.5× P/E·Price updated Jun 19, 2026
AboutLabcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.Show more
- Revenue$13.95B+7.2%
- EBITDA$2.2B+27.0%
- Net Income$877M+17.5%
- EPS (Diluted)10.46+18.3%
- Gross Margin26.75%-4.0%
- EBITDA Margin15.75%+18.4%
- Operating Margin10.87%+30.1%
- Net Margin6.28%+9.6%
- ROE10.5%+12.2%
LH Key Insights
Labcorp Holdings Inc. (LH) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong Piotroski F-Score: 7/9
- ✓High quality earnings: Operating CF exceeds net income
✗Weaknesses
- ✗Profits declining 10.8% over 5 years
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when LH posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
LH Price & Volume
Labcorp Holdings Inc. (LH) stock price & volume — 10-year historical chart
Loading chart...
LH Growth Metrics
Labcorp Holdings Inc. (LH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years4.86%
5 Years-0.04%
3 Years5.55%
TTM7.34%
Profit CAGR
10 Years7.21%
5 Years-10.85%
3 Years-11.84%
TTM28.83%
EPS CAGR
10 Years9.2%
5 Years-8.01%
3 Years-9.17%
TTM30.22%
Return on Capital
10 Years10.22%
5 Years9.63%
3 Years7.42%
Last Year9.9%
LH Recent Earnings
Labcorp Holdings Inc. (LH) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
Apr 30, 2026Metric
Actual
Est
EPS
$4.25+3.4%
$4.11
Rev
$3.5B+0.8%
$3.5B
Q1 2026
Feb 17, 2026Metric
Actual
Est
EPS
$4.07+3.0%
$3.95
Rev
$3.5B-1.2%
$3.6B
Q4 2025
Oct 28, 2025Metric
Actual
Est
EPS
$4.18+1.2%
$4.13
Rev
$3.6B+0.2%
$3.6B
Q3 2025
Jul 24, 2025Metric
Actual
Est
EPS
$4.35+4.3%
$4.17
Rev
$3.5B+1.2%
$3.5B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 30, 2026 | $4.25vs $4.11+3.4% | $3.5Bvs $3.5B+0.8% |
| Q1 2026 | Feb 17, 2026 | $4.07vs $3.95+3.0% | $3.5Bvs $3.6B-1.2% |
| Q4 2025 | Oct 28, 2025 | $4.18vs $4.13+1.2% | $3.6Bvs $3.6B+0.2% |
| Q3 2025 | Jul 24, 2025 | $4.35vs $4.17+4.3% | $3.5Bvs $3.5B+1.2% |
Based on last 12 quarters of dataView full earnings history →
LH Peer Comparison
Labcorp Holdings Inc. (LH) competitors in Diagnostics and Lab Testing Services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 DGX | 21.58B | 195.00 | 22.29 | 11.78% | 9.08% | 13.8% | 0.95 | |
 SLNO | 2.76B | 53.01 | 135.92 | 33.7% | 22.86% | 0.01 | ||
 EXAS | 20.02B | 104.91 | -95.37 | 17.69% | -6.4% | -8.66% | 1.05 | |
 BIO | 7.63B | 282.44 | 10.13 | 0.65% | 6.52% | 2.4% | 0.21 | |
 NTRA | 33.14B | 231.41 | -152.24 | 35.9% | -9.05% | -15.13% | 0.13 | |
 IQV | 28.47B | 167.77 | 21.40 | 5.87% | 8.33% | 22.11% | 2.44 | |
 CRL | 8.91B | 185.00 | -63.57 | -0.85% | -4.59% | -5.66% | 0.95 | |
 MEDP | 13.14B | 460.20 | 30.12 | 19.97% | 17.19% | 120.89% | 0.55 |
Compare LH vs Peers
Labcorp Holdings Inc. (LH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
LH Income Statement
Labcorp Holdings Inc. (LH) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 10.44B | 11.33B | 11.55B | 13.98B | 13.14B | 11.86B | 12.16B | 13.01B | 13.95B | 14.14B |
Revenue Growth % | 8.29% | 8.54% | 1.95% | 20.98% | -6.03% | -9.68% | 2.51% | 6.97% | 7.25% | 7.34% |
Cost of Goods Sold | 6.98B | 8.16B | 8.3B | 9.03B | 8.14B | 8.15B | 8.8B | 9.38B | 10.22B | 10.21B |
COGS % of Revenue | 66.82% | 71.97% | 71.85% | 64.57% | 61.99% | 68.74% | 72.33% | 72.14% | 73.25% | - |
Gross Profit | 3.46B▲ 0% | 3.18B▼ 8.3% | 3.25B▲ 2.4% | 4.95B▲ 52.3% | 4.99B▲ 0.8% | 3.71B▼ 25.7% | 3.36B▼ 9.3% | 3.62B▲ 7.7% | 3.73B▲ 3.0% | 3.93B▲ 0% |
Gross Margin % | 33.18% | 28.03% | 28.15% | 35.43% | 38.01% | 31.26% | 27.67% | 27.86% | 26.75% | 27.79% |
Gross Profit Growth % | 8.91% | -8.3% | 2.4% | 52.28% | 0.8% | -25.71% | -9.28% | 7.71% | 2.98% | - |
Operating Expenses | 2.03B | 1.8B | 1.87B | 2.51B | 1.94B | 2.27B | 2.64B | 2.54B | 2.22B | 2.37B |
OpEx % of Revenue | 19.43% | 15.91% | 16.16% | 17.94% | 14.8% | 19.15% | 21.7% | 19.51% | 15.89% | - |
Selling, General & Admin | 1.81B | 1.57B | 1.62B | 1.73B | 1.69B | 2B | 2.02B | 2.23B | 2.22B | 2.22B |
SG&A % of Revenue | 17.36% | 13.86% | 14.06% | 12.37% | 12.87% | 16.83% | 16.62% | 17.14% | 15.89% | - |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 2M | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - | - | - | 0.02% | - | - | - |
Other Operating Expenses | -7.6M | 167.7M | 243.2M | 778.1M | 253.5M | 275.8M | 615.9M | 307.7M | 0 | 2M |
Operating Income | 1.36B▲ 0% | 1.33B▼ 2.8% | 1.33B▲ 0.3% | 2.45B▲ 83.8% | 3.05B▲ 24.7% | 1.44B▼ 52.9% | 725.6M▼ 49.5% | 1.09B▲ 49.8% | 1.52B▲ 39.5% | 1.56B▲ 0% |
Operating Margin % | 13.07% | 11.7% | 11.51% | 17.49% | 23.21% | 12.11% | 5.97% | 8.35% | 10.87% | 11.03% |
Operating Income Growth % | 3.95% | -2.82% | 0.34% | 83.84% | 24.67% | -52.88% | -49.49% | 49.77% | 39.52% | - |
EBITDA | 1.9B | 1.88B | 2.1B | 3.27B | 3.63B | 1.97B | 1.3B | 1.73B | 2.2B | 2.25B |
EBITDA Margin % | 18.17% | 16.57% | 18.19% | 23.4% | 27.6% | 16.64% | 10.71% | 13.3% | 15.75% | 15.89% |
EBITDA Growth % | 5.24% | -1.03% | 11.91% | 55.62% | 10.86% | -45.56% | -33.99% | 32.8% | 27% | 28.66% |
D&A (Non-Cash Add-back) | 533.2M | 552.1M | 771.3M | 825M | 577M | 537.2M | 577.3M | 643.5M | 681.1M | 687.6M |
EBIT | 1.31B | 1.51B | 1.35B | 2.43B | 3.1B | 1.42B | 768.5M | 1.17B | 1.33B | 1.39B |
Net Interest Income | -235.1M | -244.2M | -240.7M | -207.4M | -211.8M | -179.8M | -199.6M | -208.3M | -208.9M | -205.8M |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15.2M | 17.4M |
Interest Expense | 235.1M | 244.2M | 240.7M | 207.4M | 211.8M | 179.8M | 199.6M | 208.3M | 224.1M | 223.2M |
Other Income/Expense | -227.7M | -57.4M | -225.3M | -226.3M | -161M | -199.1M | -156.7M | -127.2M | -408.7M | -408.3M |
Pretax Income | 1.13B▲ 0% | 1.27B▲ 11.8% | 1.1B▼ 12.9% | 2.22B▲ 100.8% | 2.89B▲ 30.1% | 1.24B▼ 57.1% | 568.9M▼ 54.0% | 959.5M▲ 68.7% | 1.11B▲ 15.4% | 1.15B▲ 0% |
Pretax Margin % | 10.87% | 11.19% | 9.56% | 15.88% | 21.98% | 10.43% | 4.68% | 7.38% | 7.94% | 8.14% |
Income Tax | -139.1M | 384.4M | 280M | 662.1M | 690M | 233.9M | 188.5M | 212.4M | 229.8M | 209.3M |
Effective Tax Rate % | -12.26% | 30.31% | 25.34% | 29.84% | 23.9% | 18.9% | 33.13% | 22.14% | 20.75% | 18.17% |
Net Income | 1.27B▲ 0% | 883.7M▼ 30.3% | 823.8M▼ 6.8% | 1.56B▲ 88.9% | 2.38B▲ 52.8% | 1.28B▼ 46.2% | 418M▼ 67.3% | 746M▲ 78.5% | 876.5M▲ 17.5% | 941.5M▲ 0% |
Net Margin % | 12.15% | 7.8% | 7.13% | 11.13% | 18.1% | 10.78% | 3.44% | 5.73% | 6.28% | 6.66% |
Net Income Growth % | 73.23% | -30.32% | -6.78% | 88.89% | 52.77% | -46.2% | -67.32% | 78.47% | 17.49% | 28.83% |
Net Income (Continuing) | 1.23B | 883.9M | 824.9M | 1.56B | 2.2B | 1B | 380.4M | 747.1M | 877.7M | 942.5M |
Discontinued Operations | 0 | 0 | 0 | 0 | 181.9M | 277.1M | 38.8M | 0 | 0 | 0 |
Minority Interest | 20.8M | 19.1M | 20.1M | 20.7M | 20.6M | 18.9M | 15.5M | 14.3M | 16.9M | 16.9M |
EPS (Diluted) | 12.21▲ 0% | 8.61▼ 29.5% | 8.36▼ 2.9% | 15.88▲ 90.0% | 24.38▲ 53.5% | 13.96▼ 42.7% | 4.77▼ 65.8% | 8.84▲ 85.3% | 10.46▲ 18.3% | 11.36▲ 0% |
EPS Growth % | 73.93% | -29.48% | -2.9% | 89.95% | 53.53% | -42.74% | -65.83% | 85.32% | 18.33% | 30.22% |
EPS (Basic) | 12.39 | 8.71 | 8.41 | 15.99 | 24.58 | 14.04 | 4.80 | 8.89 | 10.54 | - |
Diluted Shares Outstanding | 103.9M | 102.6M | 98.6M | 98M | 97.5M | 91.6M | 87.6M | 84.4M | 83.8M | 82.9M |
Basic Shares Outstanding | 102.4M | 101.4M | 97.9M | 97.3M | 96.7M | 91.1M | 87.1M | 83.9M | 83.2M | 82.3M |
Dividend Payout Ratio | - | - | - | - | - | 15.26% | 60.77% | 32.59% | 27.46% | - |
LH Balance Sheet
Labcorp Holdings Inc. (LH) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 2.68B | 2.84B | 2.98B | 5.13B | 5.33B | 4.63B | 3.77B | 4.81B | 4.02B | 4.56B |
Cash & Short-Term Investments | 316.7M | 426.8M | 337.5M | 1.32B | 1.47B | 320.6M | 536.8M | 1.52B | 532.3M | 981.1M |
Cash Only | 316.6M | 426.8M | 337.5M | 1.32B | 1.47B | 320.6M | 536.8M | 1.52B | 532.3M | 981.1M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 1.85B | 1.86B | 2.03B | 3.02B | 2.98B | 2B | 2.1B | 2.1B | 2.26B | 2.29B |
Days Sales Outstanding | 64.58 | 59.98 | 63.98 | 78.77 | 82.76 | 61.45 | 62.99 | 58.84 | 59.14 | 58.65 |
Inventory | 227.6M | 237.3M | 244.7M | 423.2M | 401.4M | 470.6M | 474.6M | 493.2M | 534.7M | 497.7M |
Days Inventory Outstanding | 11.91 | 10.62 | 10.76 | 17.11 | 17.99 | 21.06 | 19.69 | 19.18 | 19.1 | 18.42 |
Other Current Assets | 88.9M | 0 | 0 | 0 | 0 | 1.84B | 655.3M | 697.6M | 692.8M | 791.4M |
Total Non-Current Assets | 13.89B | 13.35B | 15.04B | 14.95B | 15.05B | 15.53B | 12.96B | 13.57B | 14.37B | 14.53B |
Property, Plant & Equipment | 1.75B | 1.78B | 2.61B | 2.73B | 2.82B | 2.79B | 2.91B | 3.05B | 3.08B | 3.07B |
Fixed Asset Turnover | 5.97x | 6.35x | 4.42x | 5.12x | 4.67x | 4.25x | 4.18x | 4.27x | 4.53x | 4.57x |
Goodwill | 7.53B | 7.36B | 7.87B | 7.75B | 7.96B | 6.12B | 6.14B | 6.37B | 6.79B | 6.96B |
Intangible Assets | 4.34B | 3.91B | 4.03B | 3.96B | 3.74B | 3.12B | 3.34B | 3.49B | 3.6B | 3.64B |
Long-Term Investments | 58.4M | 60.5M | 84.9M | 73.5M | 60.9M | 65.7M | 26.9M | 16.3M | 153.9M | 629.1M |
Other Non-Current Assets | 605.3M | 276M | 435.4M | 410M | 462.6M | 3.42B | 536.5M | 652.2M | 751.3M | 724.9M |
Total Assets | 16.57B▲ 0% | 16.19B▼ 2.3% | 18.02B▲ 11.3% | 20.07B▲ 11.4% | 20.39B▲ 1.6% | 20.16B▼ 1.1% | 16.73B▼ 17.0% | 18.38B▲ 9.9% | 18.39B▲ 0.1% | 19.09B▲ 0% |
Asset Turnover | 0.63x | 0.70x | 0.64x | 0.70x | 0.64x | 0.59x | 0.73x | 0.71x | 0.76x | 0.77x |
Asset Growth % | 16.29% | -2.31% | 11.34% | 11.38% | 1.56% | -1.13% | -17.02% | 9.89% | 0.07% | 14.68% |
Total Current Liabilities | 2.19B | 1.88B | 2.66B | 3.08B | 2.78B | 3.08B | 3.23B | 3.33B | 2.82B | 2.64B |
Accounts Payable | 573.9M | 634.6M | 632.3M | 638.9M | 621.3M | 852.2M | 827.5M | 875.8M | 840.8M | 695.7M |
Days Payables Outstanding | 30.02 | 28.4 | 27.8 | 25.84 | 27.85 | 38.14 | 34.34 | 34.06 | 30.03 | 26.78 |
Short-Term Debt | 409.2M | 10M | 415.2M | 376.7M | 1.5M | 301.3M | 999.8M | 1B | 695.8M | 688.2M |
Deferred Revenue (Current) | 380.8M | 356.4M | 451M | 506.5M | 558.5M | 310.6M | 421.7M | 392.2M | 439.1M | 1.63B |
Other Current Liabilities | 432.8M | 427.6M | 474.6M | 623.2M | 735.5M | 1.1B | 431.4M | 495.4M | 847.8M | 851.9M |
Current Ratio | 1.23x | 1.51x | 1.12x | 1.66x | 1.92x | 1.50x | 1.17x | 1.44x | 1.42x | 1.73x |
Quick Ratio | 1.12x | 1.38x | 1.03x | 1.53x | 1.77x | 1.35x | 1.02x | 1.30x | 1.23x | 1.54x |
Cash Conversion Cycle | 46.47 | 42.2 | 46.94 | 70.05 | 72.9 | 44.37 | 48.34 | 43.96 | 48.21 | 50.29 |
Total Non-Current Liabilities | 7.66B | 7.32B | 7.8B | 7.54B | 7.31B | 6.96B | 5.61B | 6.98B | 6.93B | 7.7B |
Long-Term Debt | 6.29B | 5.99B | 5.79B | 5.42B | 5.42B | 5.04B | 4.05B | 5.33B | 5.77B | 6.55B |
Capital Lease Obligations | 57.8M | 51M | 687.7M | 762M | 727.1M | 736.5M | 727.5M | 750.6M | 745.6M | 2.28B |
Deferred Tax Liabilities | 875.5M | 940M | 942.8M | 828.5M | 762.9M | 543.4M | 417.9M | 383.1M | 454.5M | 1.71B |
Other Non-Current Liabilities | 442.3M | 334M | 383.2M | 526.4M | 402M | 642.4M | 409.3M | 517.4M | -34.8M | 691.8M |
Total Liabilities | 9.85B | 9.19B | 10.46B | 10.61B | 10.09B | 10.04B | 8.83B | 10.31B | 9.76B | 10.34B |
Total Debt | 6.76B | 6.06B | 7.11B | 6.76B | 6.34B | 6.25B | 5.95B | 7.27B | 7.2B | 7.24B |
Net Debt | 6.45B | 5.63B | 6.77B | 5.44B | 4.87B | 5.93B | 5.42B | 5.75B | 6.67B | 6.26B |
Debt / Equity | 0.99x | 0.87x | 0.94x | 0.71x | 0.62x | 0.62x | 0.75x | 0.90x | 0.83x | 0.83x |
Debt / EBITDA | 3.56x | 3.23x | 3.38x | 2.07x | 1.75x | 3.16x | 4.57x | 4.20x | 3.28x | 3.22x |
Net Debt / EBITDA | 3.40x | 3.00x | 3.22x | 1.66x | 1.34x | 3.00x | 4.16x | 3.33x | 3.04x | 2.78x |
Interest Coverage | 5.58x | 6.19x | 5.59x | 11.70x | 14.63x | 7.88x | 3.85x | 5.61x | 5.94x | 6.22x |
Total Equity | 6.82B▲ 0% | 6.99B▲ 2.4% | 7.59B▲ 8.5% | 9.46B▲ 24.6% | 10.29B▲ 8.8% | 10.12B▼ 1.7% | 7.89B▼ 22.0% | 8.07B▲ 2.2% | 8.64B▲ 7.1% | 8.75B▲ 0% |
Equity Growth % | 23.62% | 2.43% | 8.53% | 24.65% | 8.85% | -1.73% | -22% | 2.23% | 7.07% | 24.45% |
Book Value per Share | 65.69 | 68.13 | 76.95 | 96.50 | 105.58 | 110.43 | 90.07 | 95.57 | 103.06 | 105.49 |
Total Shareholders' Equity | 6.8B | 6.97B | 7.57B | 9.44B | 10.27B | 10.1B | 7.88B | 8.05B | 8.62B | 8.73B |
Common Stock | 12M | 11.7M | 9M | 9M | 8.5M | 8.1M | 7.7M | 7.6M | 7.5M | 7.4M |
Retained Earnings | 6.22B | 7.08B | 7.9B | 9.48B | 10.46B | 10.58B | 7.89B | 8.3B | 8.64B | 8.78B |
Treasury Stock | -1.06B | -1.11B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -335.7M | -463.1M | -372.4M | -161.9M | -192M | -493.2M | -59.3M | -261.6M | -27.6M | -63.2M |
Minority Interest | 20.8M | 19.1M | 20.1M | 20.7M | 20.6M | 18.9M | 15.5M | 14.3M | 16.9M | 16.9M |
LH Cash Flow Statement
Labcorp Holdings Inc. (LH) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 1.46B | 1.31B | 1.44B | 2.14B | 3.11B | 1.96B | 1.33B | 1.59B | 1.64B | 1.81B |
Operating CF Margin % | 13.98% | 11.52% | 12.5% | 15.28% | 23.67% | 16.49% | 10.92% | 12.19% | 11.76% | - |
Operating CF Growth % | 24.11% | -10.55% | 10.67% | 47.8% | 45.63% | -37.1% | -32.12% | 19.44% | 3.45% | 964.4% |
Net Income | 1.27B | 883.9M | 824.9M | 1.56B | 2.38B | 1B | 379.2M | 746M | 877.7M | 941.5M |
Depreciation & Amortization | 533.2M | 552.1M | 577.2M | 624.7M | 577M | 537.2M | 577.3M | 643.5M | 681.1M | 687.6M |
Stock-Based Compensation | 109.7M | 91.6M | 107M | 111.7M | 132.9M | 116.8M | 128.7M | 116.7M | 125.8M | 124.7M |
Deferred Taxes | -542.2M | 22.2M | 29.2M | -47M | -37.3M | 26.3M | -78.1M | -20.1M | 97.6M | 105.7M |
Other Non-Cash Items | 25.8M | -174.1M | 200.8M | 745.8M | 321.2M | 875.5M | 682.5M | 253.8M | 384.4M | 648.6M |
Working Capital Changes | 58.9M | -70.3M | -294.4M | -856.9M | -263.7M | -603.4M | -361.9M | -154.1M | -526.1M | -434.3M |
Change in Receivables | -2.1M | 50.2M | -64.1M | -955.9M | 222M | 15.9M | -75.3M | 98.5M | -122.2M | -149.4M |
Change in Inventory | -16.4M | -18.9M | -21.9M | -196.6M | 2.8M | -45.5M | -700K | -14.6M | -30.2M | -3.2M |
Change in Payables | 85.6M | 43.3M | -12.8M | -5.3M | -10.2M | 307.1M | -42.4M | 210.3M | -52.8M | -43.9M |
Cash from Investing | -2.23B | 206.7M | -1.28B | -643.2M | -884.6M | -1.65B | -1.17B | -1.37B | -1.19B | -1.18B |
Capital Expenditures | -315.4M | -379.8M | -400.2M | -381.7M | -460.4M | -481.9M | -453.6M | -489.9M | -434.5M | -429.5M |
CapEx % of Revenue | 3.02% | 3.35% | 3.46% | 2.73% | 3.5% | 4.06% | 3.73% | 3.77% | 3.11% | 3.04% |
Acquisitions | -1.92B | -136.4M | -876M | -267.6M | -496.9M | -1.16B | -671.5M | -823.9M | -582M | -730.7M |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 5.5M | 324.8M | 7.7M | 42.1M | 87.3M | 1.4M | -24.1M | 2M | 8M | 15.3M |
Cash from Financing | 631.9M | -1.39B | -252.7M | -517.4M | -2.07B | -1.32B | -59.3M | 779.9M | -1.46B | -36.8M |
Debt Issued (Net) | 956.9M | -695M | 210.1M | -412.2M | -375M | 0 | -300M | 1B | -775M | 910.2M |
Equity Issued (Net) | -385.5M | -700M | -490.6M | -134.5M | -1.72B | -1.15B | -1.04B | -250.1M | -395.7M | -486.5M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | -195.2M | -254M | -243.1M | -240.7M | -240.3M |
Share Repurchases | -338.1M | -700M | -450M | -134.5M | -1.72B | -1.15B | -1.04B | -250.1M | -450M | -548M |
Other Financing | 21.8M | 5.1M | 27.8M | 29.3M | 25.2M | 23.6M | 1.53B | 273.1M | -45.6M | -220.2M |
Net Change in Cash | -116.9M▲ 0% | 110.2M▲ 194.3% | -89.3M▼ 181.0% | 983.3M▲ 1201.1% | 151.9M▼ 84.6% | -1.04B▼ 786.4% | 106.8M▲ 110.2% | 981.9M▲ 819.4% | -986.4M▼ 200.5% | 611.7M▲ 0% |
Free Cash Flow | 1.14B▲ 0% | 925.6M▼ 19.1% | 1.04B▲ 12.8% | 1.75B▲ 67.9% | 2.65B▲ 51.1% | 1.47B▼ 44.4% | 874.1M▼ 40.7% | 1.1B▲ 25.4% | 1.21B▲ 10.0% | 1.38B▲ 0% |
FCF Margin % | 10.96% | 8.17% | 9.04% | 12.54% | 20.17% | 12.42% | 7.19% | 8.42% | 8.64% | 9.78% |
FCF Growth % | 27.54% | -19.09% | 12.85% | 67.89% | 51.07% | -44.36% | -40.7% | 25.37% | 10.05% | 20.14% |
FCF per Share | 11.01 | 9.02 | 10.59 | 17.89 | 27.17 | 16.09 | 9.98 | 12.98 | 14.39 | 16.69 |
FCF Conversion (FCF/Net Income) | 1.15x | 1.48x | 1.75x | 1.37x | 1.31x | 1.53x | 3.18x | 2.13x | 1.87x | 1.47x |
Interest Paid | 239.1M | 296.2M | 0 | 216.6M | 194.5M | 196.7M | 221.5M | 209.2M | 0 | 0 |
Taxes Paid | 348M | 349.7M | 0 | 500M | 964.7M | 474.9M | 206.8M | 215.4M | 0 | 0 |
LH Key Ratios
Labcorp Holdings Inc. (LH) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 20.54% | 12.79% | 11.3% | 18.26% | 24.07% | 12.53% | 4.64% | 9.35% | 10.5% | 10.89% |
Return on Invested Capital (ROIC) | 8.45% | 7.68% | 7.4% | 12.54% | 15.21% | 6.91% | 3.71% | 6.01% | 7.81% | 7.8% |
Gross Margin | 33.18% | 28.03% | 28.15% | 35.43% | 38.01% | 31.26% | 27.67% | 27.86% | 26.75% | 27.79% |
Net Margin | 12.15% | 7.8% | 7.13% | 11.13% | 18.1% | 10.78% | 3.44% | 5.73% | 6.28% | 6.66% |
Debt / Equity | 0.99x | 0.87x | 0.94x | 0.71x | 0.62x | 0.62x | 0.75x | 0.90x | 0.83x | 0.83x |
Interest Coverage | 5.58x | 6.19x | 5.59x | 11.70x | 14.63x | 7.88x | 3.85x | 5.61x | 5.94x | 6.22x |
FCF Conversion | 1.15x | 1.48x | 1.75x | 1.37x | 1.31x | 1.53x | 3.18x | 2.13x | 1.87x | 1.47x |
Revenue Growth | 8.29% | 8.54% | 1.95% | 20.98% | -6.03% | -9.68% | 2.51% | 6.97% | 7.25% | 7.34% |
Related:LH Dividend History·LH Revenue History·LH Price History·LH P/E History·LH Financial Ratios·LH Institutional Holders
LH SEC Filings & Documents
Labcorp Holdings Inc. (LH) SEC filings — annual & quarterly reports (10-K, 10-Q)
LH Frequently Asked Questions
Labcorp Holdings Inc. (LH) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Labcorp Holdings Inc. (LH) reported $14.14B in revenue for fiscal year 2025. This represents a 780% increase from $1.61B in 1996.
Labcorp Holdings Inc. (LH) grew revenue by 7.2% over the past year. This is steady growth.
Yes, Labcorp Holdings Inc. (LH) is profitable, generating $941.5M in net income for fiscal year 2025 (6.3% net margin).
Dividend & Returns
Yes, Labcorp Holdings Inc. (LH) pays a dividend with a yield of 1.12%. This makes it attractive for income-focused investors.
Labcorp Holdings Inc. (LH) has a return on equity (ROE) of 10.5%. This is reasonable for most industries.
Labcorp Holdings Inc. (LH) generated $1.38B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.